13-02-2020
Michael Vi / Shutterstock.com
US biotechnology company 10x Genomics has won an import ban against its rival Bio-Rad Laboratories in a long-running patent dispute.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
10x Genomics, Bio-Rad Laboratories, US International Trade Commission, ITC, microfluidics
Bio-Rad and 10X Genomics end patent fight with new licensing deal
29-07-2021
Bio-Rad asks for review of DNA patent ruling
17-06-2021
Federal Circuit upholds another ITC decision in 10X vs Bio-Rad
03-06-2021
Fed Circ. agrees Bio-Rad infringed 10x patents
04-05-2021
Fed Circuit orders new Bio-Rad trial, but upholds $24m award
04-08-2020
USITC to review long-running Zimmer/Heraeus trade secrets dispute
14-07-2020
Munich court rules for Bio-Rad in 10x Genomics dispute
03-12-2019
